Your browser doesn't support javascript.
Association of mental disorders with SARS-CoV-2 infection and severe health outcomes: nationwide cohort study.
Jeon, Ha-Lim; Kwon, Jun Soo; Park, So-Hee; Shin, Ju-Young.
  • Jeon HL; School of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea.
  • Kwon JS; Department of Psychiatry, Seoul National University College of Medicine, Republic of Korea; and Department of Neuropsychiatry, Seoul National University Hospital, Republic of Korea; and Department of Brain and Cognitive Sciences, Seoul National University College of Natural Sciences, Republic of Kor
  • Park SH; School of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea.
  • Shin JY; School of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea; and Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, Seoul, Republic of Korea.
Br J Psychiatry ; 218(6): 344-351, 2021 06.
Article in English | MEDLINE | ID: covidwho-1013165
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
ABSTRACT

BACKGROUND:

Epidemiological data on the association between mental disorders and the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-19) severity are limited.

AIMS:

To evaluate the association between mental disorders and the risk of SARS-CoV-2 infection and severe outcomes following COVID-19.

METHOD:

We performed a cohort study using the Korean COVID-19 patient database based on national health insurance data. Each person with a mental or behavioural disorder (diagnosed during the 6 months prior to their first SARS-CoV-2 test) was matched by age, gender and Charlson Comorbidity Index with up to four people without mental disorders. SARS-CoV-2-positivity risk and the risk of death or severe events (intensive care unit admission, use of mechanical ventilation and acute respiratory distress syndrome) post-infection were calculated using conditional logistic regression analysis.

RESULTS:

Among 230 565 people tested for SARS-CoV-2, 33 653 (14.6%) had mental disorders; 928/33 653 (2.76%) tested SARS-CoV-2 positive and 56/928 (6.03%) died. In multivariable analysis using the matched cohort, there was no association between mental disorders and SARS-CoV-2-positivity risk (odds ratio OR = 0.95; 95% CI 0.87-1.04); however, a higher risk was associated with schizophrenia-related disorders (OR = 1.50; 95% CI 1.14-1.99). Among confirmed COVID-19 patients, the mortality risk was significantly higher in patients with than in those without mental disorders (OR = 1.99, 95% CI 1.15-3.43).

CONCLUSIONS:

Mental disorders are likely contributing factors to mortality following COVID-19. Although the infection risk was not higher for people with mental disorders overall, those with schizophrenia-related disorders were more vulnerable to infection.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Mental Disorders Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Br J Psychiatry Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Mental Disorders Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Br J Psychiatry Year: 2021 Document Type: Article